{"filing":{"accession_number":"0001193125-26-297475","cik":"0001534133","ticker":"CALC","company_name":"CalciMedica, Inc.","form":"8-K","filing_date":"2026-07-07","report_date":null,"primary_document":"ck0001534133-20260702.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312526297475/ck0001534133-20260702.htm"},"events":[{"id":16421,"run_id":14674,"accession_number":"0001193125-26-297475","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"The filing discloses the appointment of Evgeny Zaytsev, M.D., Ph.D. as a Class I director effective immediately, with the Board increasing from seven to eight directors. While the section also mentions Fred Middleton's retirement, the principal disclosed action centers on the new director appointment. The appointment includes standard director compensation (annual cash retainer of $40,000 and a 20,000-share option grant vesting over three years), which is material to investors assessing board composition and governance.","company_name":"CalciMedica, Inc.","ticker":"CALC","filing_date":"2026-07-07","form":"8-K","submitted_at":null,"items":[{"id":14514,"accession_number":"0001193125-26-297475","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses the appointment of Evgeny Zaytsev, M.D., Ph.D. as a Class I director effective immediately, with the Board increasing from seven to eight directors. While the section also mentions Fred Middleton's retirement, the principal disclosed action centers on the new director appointment. The appointment includes standard director compensation (annual cash retainer of $40,000 and a 20,000-share option grant vesting over three years), which is material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T20:11:37.649589+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14514,"accession_number":"0001193125-26-297475","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses the appointment of Evgeny Zaytsev, M.D., Ph.D. as a Class I director effective immediately, with the Board increasing from seven to eight directors. While the section also mentions Fred Middleton's retirement, the principal disclosed action centers on the new director appointment. The appointment includes standard director compensation (annual cash retainer of $40,000 and a 20,000-share option grant vesting over three years), which is material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T20:11:37.649589+00:00","company_name":"CalciMedica, Inc.","ticker":"CALC","filing_date":"2026-07-07"}]}